> top > docs > PMC:7205724 > spans > 340-647 > annotations

PMC:7205724 / 340-647 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
7 74-82 Disease denotes COVID-19 MESH:C000657245
10 87-90 Gene denotes IL6 Gene:3569
11 159-167 Disease denotes COVID-19 MESH:C000657245
17 193-196 Gene denotes IL6 Gene:3569
18 252-255 Gene denotes IL6 Gene:3569
19 220-228 Species denotes patients Tax:9606
20 172-183 Chemical denotes Tocilizumab MESH:C502936
21 234-242 Disease denotes COVID-19 MESH:C000657245
53 271-288 Species denotes novel coronavirus Tax:2697049
54 290-299 Species denotes SARS-CoV2 Tax:2697049

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T3 74-82 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T4 159-167 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T5 234-242 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T6 290-294 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T5 54-69 Chemical denotes corticosteroids http://purl.obolibrary.org/obo/CHEBI_50858

LitCovid-sample-MedDRA

Id Subject Object Predicate Lexical cue meddra_id
T2 130-140 http://purl.bioontology.org/ontology/MEDDRA/10022891 denotes viral load http://purl.bioontology.org/ontology/MEDDRA/10062178

LitCovid-sample-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T4 54-69 Chemical denotes corticosteroids http://purl.obolibrary.org/obo/CHEBI_50858

LitCovid-sample-PD-NCBITaxon

Id Subject Object Predicate Lexical cue ncbi_taxonomy_id
T3 74-82 Species denotes COVID-19 NCBItxid:2697049
T4 159-167 Species denotes COVID-19 NCBItxid:2697049
T5 234-242 Species denotes COVID-19 NCBItxid:2697049
T6 290-299 Species denotes SARS-CoV2 NCBItxid:2697049

LitCovid-sample-sentences

Id Subject Object Predicate Lexical cue
T7 1-83 Sentence denotes • No controlled clinical trials exist on the use of corticosteroids for COVID-19.
T8 84-168 Sentence denotes • IL6 correlates with severity, criticality, viral load, and prognosis of COVID-19.
T9 169-256 Sentence denotes • Tocilizumab, an anti-IL6, can confer benefit in patients with COVID-19 and high IL6.
T10 258-266 Sentence denotes Abstract

LitCovid-sample-Pubtator

Id Subject Object Predicate Lexical cue pubann:denotes
7 74-82 Disease denotes COVID-19 MESH:C000657245
10 87-90 Gene denotes IL6 Gene:3569
11 159-167 Disease denotes COVID-19 MESH:C000657245
20 172-183 Chemical denotes Tocilizumab MESH:C502936
17 193-196 Gene denotes IL6 Gene:3569
19 220-228 Species denotes patients Tax:9606
21 234-242 Disease denotes COVID-19 MESH:C000657245
18 252-255 Gene denotes IL6 Gene:3569
53 271-288 Species denotes novel coronavirus Tax:2697049
54 290-299 Species denotes SARS-CoV2 Tax:2697049

LitCovid-sample-UniProt

Id Subject Object Predicate Lexical cue uniprot_id
T1 87-90 Protein denotes IL6 https://www.uniprot.org/uniprot/Q9XT80|https://www.uniprot.org/uniprot/Q9UCU4|https://www.uniprot.org/uniprot/Q9UCU3|https://www.uniprot.org/uniprot/Q9UCU2|https://www.uniprot.org/uniprot/Q9MZR1|https://www.uniprot.org/uniprot/Q9MYZ7|https://www.uniprot.org/uniprot/Q95KN6|https://www.uniprot.org/uniprot/Q95181|https://www.uniprot.org/uniprot/Q90YI0|https://www.uniprot.org/uniprot/Q8MKH0|https://www.uniprot.org/uniprot/Q8BN26|https://www.uniprot.org/uniprot/Q865X6|https://www.uniprot.org/uniprot/Q865W7|https://www.uniprot.org/uniprot/Q6V919|https://www.uniprot.org/uniprot/Q6L6X6|https://www.uniprot.org/uniprot/Q5I6E3|https://www.uniprot.org/uniprot/Q3UCQ0|https://www.uniprot.org/uniprot/Q2MH06|https://www.uniprot.org/uniprot/Q28819|https://www.uniprot.org/uniprot/Q28747|https://www.uniprot.org/uniprot/Q28319|https://www.uniprot.org/uniprot/Q25BC2|https://www.uniprot.org/uniprot/Q0PW36|https://www.uniprot.org/uniprot/Q0GGL7|https://www.uniprot.org/uniprot/Q08DT2|https://www.uniprot.org/uniprot/P79341|https://www.uniprot.org/uniprot/P51494|https://www.uniprot.org/uniprot/P46650|https://www.uniprot.org/uniprot/P41693|https://www.uniprot.org/uniprot/P41683|https://www.uniprot.org/uniprot/P41323|https://www.uniprot.org/uniprot/P29455|https://www.uniprot.org/uniprot/P26893|https://www.uniprot.org/uniprot/P26892|https://www.uniprot.org/uniprot/P20607|https://www.uniprot.org/uniprot/P08505|https://www.uniprot.org/uniprot/P05231|https://www.uniprot.org/uniprot/O46568|https://www.uniprot.org/uniprot/O35736|https://www.uniprot.org/uniprot/O19007|https://www.uniprot.org/uniprot/B6CKP4|https://www.uniprot.org/uniprot/A9QWQ9|https://www.uniprot.org/uniprot/A3FBE9|https://www.uniprot.org/uniprot/A0S0B0
T45 193-196 Protein denotes IL6 https://www.uniprot.org/uniprot/Q9XT80|https://www.uniprot.org/uniprot/Q9UCU4|https://www.uniprot.org/uniprot/Q9UCU3|https://www.uniprot.org/uniprot/Q9UCU2|https://www.uniprot.org/uniprot/Q9MZR1|https://www.uniprot.org/uniprot/Q9MYZ7|https://www.uniprot.org/uniprot/Q95KN6|https://www.uniprot.org/uniprot/Q95181|https://www.uniprot.org/uniprot/Q90YI0|https://www.uniprot.org/uniprot/Q8MKH0|https://www.uniprot.org/uniprot/Q8BN26|https://www.uniprot.org/uniprot/Q865X6|https://www.uniprot.org/uniprot/Q865W7|https://www.uniprot.org/uniprot/Q6V919|https://www.uniprot.org/uniprot/Q6L6X6|https://www.uniprot.org/uniprot/Q5I6E3|https://www.uniprot.org/uniprot/Q3UCQ0|https://www.uniprot.org/uniprot/Q2MH06|https://www.uniprot.org/uniprot/Q28819|https://www.uniprot.org/uniprot/Q28747|https://www.uniprot.org/uniprot/Q28319|https://www.uniprot.org/uniprot/Q25BC2|https://www.uniprot.org/uniprot/Q0PW36|https://www.uniprot.org/uniprot/Q0GGL7|https://www.uniprot.org/uniprot/Q08DT2|https://www.uniprot.org/uniprot/P79341|https://www.uniprot.org/uniprot/P51494|https://www.uniprot.org/uniprot/P46650|https://www.uniprot.org/uniprot/P41693|https://www.uniprot.org/uniprot/P41683|https://www.uniprot.org/uniprot/P41323|https://www.uniprot.org/uniprot/P29455|https://www.uniprot.org/uniprot/P26893|https://www.uniprot.org/uniprot/P26892|https://www.uniprot.org/uniprot/P20607|https://www.uniprot.org/uniprot/P08505|https://www.uniprot.org/uniprot/P05231|https://www.uniprot.org/uniprot/O46568|https://www.uniprot.org/uniprot/O35736|https://www.uniprot.org/uniprot/O19007|https://www.uniprot.org/uniprot/B6CKP4|https://www.uniprot.org/uniprot/A9QWQ9|https://www.uniprot.org/uniprot/A3FBE9|https://www.uniprot.org/uniprot/A0S0B0
T89 252-255 Protein denotes IL6 https://www.uniprot.org/uniprot/Q9XT80|https://www.uniprot.org/uniprot/Q9UCU4|https://www.uniprot.org/uniprot/Q9UCU3|https://www.uniprot.org/uniprot/Q9UCU2|https://www.uniprot.org/uniprot/Q9MZR1|https://www.uniprot.org/uniprot/Q9MYZ7|https://www.uniprot.org/uniprot/Q95KN6|https://www.uniprot.org/uniprot/Q95181|https://www.uniprot.org/uniprot/Q90YI0|https://www.uniprot.org/uniprot/Q8MKH0|https://www.uniprot.org/uniprot/Q8BN26|https://www.uniprot.org/uniprot/Q865X6|https://www.uniprot.org/uniprot/Q865W7|https://www.uniprot.org/uniprot/Q6V919|https://www.uniprot.org/uniprot/Q6L6X6|https://www.uniprot.org/uniprot/Q5I6E3|https://www.uniprot.org/uniprot/Q3UCQ0|https://www.uniprot.org/uniprot/Q2MH06|https://www.uniprot.org/uniprot/Q28819|https://www.uniprot.org/uniprot/Q28747|https://www.uniprot.org/uniprot/Q28319|https://www.uniprot.org/uniprot/Q25BC2|https://www.uniprot.org/uniprot/Q0PW36|https://www.uniprot.org/uniprot/Q0GGL7|https://www.uniprot.org/uniprot/Q08DT2|https://www.uniprot.org/uniprot/P79341|https://www.uniprot.org/uniprot/P51494|https://www.uniprot.org/uniprot/P46650|https://www.uniprot.org/uniprot/P41693|https://www.uniprot.org/uniprot/P41683|https://www.uniprot.org/uniprot/P41323|https://www.uniprot.org/uniprot/P29455|https://www.uniprot.org/uniprot/P26893|https://www.uniprot.org/uniprot/P26892|https://www.uniprot.org/uniprot/P20607|https://www.uniprot.org/uniprot/P08505|https://www.uniprot.org/uniprot/P05231|https://www.uniprot.org/uniprot/O46568|https://www.uniprot.org/uniprot/O35736|https://www.uniprot.org/uniprot/O19007|https://www.uniprot.org/uniprot/B6CKP4|https://www.uniprot.org/uniprot/A9QWQ9|https://www.uniprot.org/uniprot/A3FBE9|https://www.uniprot.org/uniprot/A0S0B0

LitCovid-sample-Enju

Id Subject Object Predicate Lexical cue
T47 1-2 PDT denotes •
T48 4-6 DT denotes No
T49 7-17 VBN denotes controlled
T50 18-26 JJ denotes clinical
T51 27-33 NNS denotes trials
T52 34-39 VBP denotes exist
T53 40-42 IN denotes on
T54 43-46 DT denotes the
T55 47-50 NN denotes use
T56 51-53 IN denotes of
T57 54-69 NNS denotes corticosteroids
T58 70-73 IN denotes for
T59 74-82 NN denotes COVID-19
T60 84-85 LS denotes •
T61 87-90 NN denotes IL6
T62 91-101 VBZ denotes correlates
T63 102-106 IN denotes with
T64 107-115 NN denotes severity
T65 115-116 -COMMA- denotes ,
T66 117-128 NN denotes criticality
T67 128-129 -COMMA- denotes ,
T68 130-135 JJ denotes viral
T69 136-140 NN denotes load
T70 140-141 -COMMA- denotes ,
T71 142-145 CC denotes and
T72 146-155 NN denotes prognosis
T73 156-158 IN denotes of
T74 159-167 NN denotes COVID-19
T75 169-170 IN denotes •
T76 172-183 NNP denotes Tocilizumab
T77 183-184 -COMMA- denotes ,
T78 185-187 DT denotes an
T79 188-196 NN denotes anti-IL6
T80 196-197 -COMMA- denotes ,
T81 198-201 MD denotes can
T82 202-208 VB denotes confer
T83 209-216 NN denotes benefit
T84 217-219 IN denotes in
T85 220-228 NNS denotes patients
T86 229-233 IN denotes with
T87 234-242 NN denotes COVID-19
T88 243-246 CC denotes and
T89 247-251 JJ denotes high
T90 252-255 NN denotes IL6
T91 258-266 NN denotes Abstract
T92 267-270 DT denotes The
T93 271-276 JJ denotes novel
T94 277-288 NN denotes coronavirus
T95 288-289 -COMMA- denotes ,
T96 290-299 NN denotes SARS-CoV2
T97 299-300 -COMMA- denotes ,
T98 301-304 MD denotes can
R43 T51 T47 arg1Of trials,•
R44 T51 T48 arg1Of trials,No
R45 T51 T49 arg2Of trials,controlled
R46 T51 T50 arg1Of trials,clinical
R47 T51 T52 arg1Of trials,exist
R48 T52 T53 arg1Of exist,on
R49 T55 T53 arg2Of use,on
R50 T55 T54 arg1Of use,the
R51 T55 T56 arg1Of use,of
R52 T57 T56 arg2Of corticosteroids,of
R53 T55 T58 arg1Of use,for
R54 T59 T58 arg2Of COVID-19,for
R55 T62 T60 arg1Of correlates,•
R56 T61 T62 arg1Of IL6,correlates
R57 T62 T63 arg1Of correlates,with
R58 T71 T63 arg2Of and,with
R59 T64 T65 arg1Of severity,","
R60 T66 T65 arg2Of criticality,","
R61 T65 T67 arg1Of ",",","
R62 T69 T67 arg2Of load,","
R63 T69 T68 arg1Of load,viral
R64 T71 T70 arg1Of and,","
R65 T67 T71 arg1Of ",",and
R66 T72 T71 arg2Of prognosis,and
R67 T72 T73 arg1Of prognosis,of
R68 T74 T73 arg2Of COVID-19,of
R69 T82 T75 arg1Of confer,•
R70 T76 T77 arg1Of Tocilizumab,","
R71 T79 T77 arg2Of anti-IL6,","
R72 T79 T78 arg1Of anti-IL6,an
R73 T82 T80 arg1Of confer,","
R74 T76 T81 arg1Of Tocilizumab,can
R75 T82 T81 arg2Of confer,can
R76 T76 T82 arg1Of Tocilizumab,confer
R77 T83 T82 arg2Of benefit,confer
R78 T82 T84 arg1Of confer,in
R79 T85 T84 arg2Of patients,in
R80 T85 T86 arg1Of patients,with
R81 T88 T86 arg2Of and,with
R82 T87 T88 arg1Of COVID-19,and
R83 T90 T88 arg2Of IL6,and
R84 T90 T89 arg1Of IL6,high
R85 T94 T92 arg1Of coronavirus,The
R86 T94 T93 arg1Of coronavirus,novel
R87 T94 T95 arg1Of coronavirus,","
R88 T96 T95 arg2Of SARS-CoV2,","
R90 T94 T98 arg1Of coronavirus,can

LitCovid-sample-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T3 74-82 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T4 159-167 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T5 234-242 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T6 290-299 Disease denotes SARS-CoV2 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T7 1-83 Sentence denotes • No controlled clinical trials exist on the use of corticosteroids for COVID-19.
T8 84-168 Sentence denotes • IL6 correlates with severity, criticality, viral load, and prognosis of COVID-19.
T9 169-256 Sentence denotes • Tocilizumab, an anti-IL6, can confer benefit in patients with COVID-19 and high IL6.
T10 258-266 Sentence denotes Abstract